• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Eyecare Leadership

anonymous

Guest
Just curious as a previous employee and someone who is still heavily invested in the company stock (I know, i know, I should have sold long ago!) What did they do with the leadership trip for the year 2017? After laying off so many, I can’t see how they could still go ahead with it. And what about the employees who would have won but were let go?
 

<























Similar threads